Zeitpunkt Nutzer Delta Tröts TNR Titel Version maxTL Mi 10.07.2024 00:00:32 2.880 0 375.027 130,2 Toot Café 4.2.10 500 Di 09.07.2024 00:01:12 2.880 0 374.874 130,2 Toot Café 4.2.10 500 Mo 08.07.2024 00:01:20 2.880 0 374.707 130,1 Toot Café 4.2.10 500 So 07.07.2024 00:00:37 2.880 0 374.585 130,1 Toot Café 4.2.10 500 Sa 06.07.2024 00:00:04 2.880 0 374.465 130,0 Toot Café 4.2.10 500 Fr 05.07.2024 00:01:16 2.880 0 374.345 130,0 Toot Café 4.2.10 500 Do 04.07.2024 00:01:17 2.880 0 374.203 129,9 Toot Café 4.2.9 500 Mi 03.07.2024 00:02:08 2.880 0 374.021 129,9 Toot Café 4.2.9 500 Di 02.07.2024 00:00:32 2.880 0 373.842 129,8 Toot Café 4.2.9 500 Mo 01.07.2024 00:02:14 2.880 0 373.716 129,8 Toot Café 4.2.9 500
David Chartier (@chartier) · 10/2018 · Tröts: 10.776 · Folger: 4.237
Mi 10.07.2024 21:09
“A large clinical trial in South Africa and Uganda has shown that a twice-yearly injection of a new pre-exposure prophylaxis drug gives young women total protection from HIV infection.
The trial tested whether the six-month injection of lenacapavir would provide better protection against HIV infection than two other drugs, both daily pills. All three medications are pre-exposure prophylaxis (or PrEP) drugs.”
https://www.sciencealert.com/new-hiv-prevention-drug-shows-100-efficacy-in-clinical-trial
[Öffentlich] Antw.: 0 Wtrl.: 0 Fav.: 0 · via Ivory for iOS